Rotavirus vaccines made available for use in humanitarian crises

Rotavirus vaccines made available for use in humanitarian crises
Health partners welcome landmark pricing agreement through Humanitarian Mechanism, urging more manufacturers to follow suit
4 March 2021 News release Geneva/London/New York
Médecins Sans Frontières (MSF), Save the Children, UNICEF and the World Health Organization (WHO) welcome the opportunity to make rotavirus vaccine available to more children living in humanitarian crises thanks to a landmark pricing agreement with the manufacturer, GSK.

Children living in refugee camps, displaced communities or in other emergency situations now have a better chance of being protected against severe diarrhoeal disease with these lower price rotavirus vaccines. Diarrhoea is one of the leading causes of death among children under five.

The agreement makes use of the multi-partner Humanitarian Mechanism, launched in 2017. Rotavirus vaccine is the second vaccine to be accessed through the scheme, which depends on manufacturers making their vaccines available at their lowest price for use in emergencies – across countries of all income levels. The first to be made available was the pneumococcal vaccine.